Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
Clinical trial NCT04330820 · UNKNOWN
Trial details
- NCT number
- NCT04330820
- Sponsor
- Technische Universität Dresden
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-06
- Primary completion
- 2023-10-11
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.